What's new

Human medicines European public assessment report (EPAR): Zinforo, ceftaroline fosamil, Date of authorisation: 22/08/2012, Revision: 28, Status: Authorised

Human medicines European public assessment report (EPAR): Zinforo, ceftaroline fosamil, Date of authorisation: 22/08/2012, Revision: 28, Status: Authorised

Feb 14, 2025 - 16:58
 0
Human medicines European public assessment report (EPAR): Zinforo, ceftaroline fosamil, Date of authorisation: 22/08/2012, Revision: 28, Status: Authorised
Human medicines European public assessment report (EPAR): Zinforo, ceftaroline fosamil, Date of authorisation: 22/08/2012, Revision: 28, Status: Authorised
Read More

Tags:

Previous Article

Allogene’s phase 1 lymphoma data show CAR-T could ‘leapfrog’ competition: analysts

Next Article

Human medicines European public assessment report (EPAR): Karvea, irbesartan, Da...

Related Posts

Pharmacovigilance Risk Assessment Committee (PRAC): 25 - 28 November 2024, European Medicines Agency, Amsterdam, the Netherlands, from 25 November 2024 to 28 November 2024

Pharmacovigilance Risk Assessment Committee (PRAC): 25 ...

Feb 10, 2025  0

Veterinary medicines European public assessment report (EPAR): Icthiovac ERM, inactivated vaccine against yersiniosis , Status: Authorised

Veterinary medicines European public assessment report ...

Feb 24, 2025  0

Human medicines European public assessment report (EPAR): Herzuma, trastuzumab, Date of authorisation: 09/02/2018, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 26, 2025  0